Technical Analysis for MLYS - Mineralys Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Crossed Above 20 DMA | Bullish | 4.06% | |
20 DMA Resistance | Bearish | 9.95% | |
Outside Day | Range Expansion | 9.95% | |
Gapped Up | Strength | 9.95% | |
20 DMA Resistance | Bearish | 5.59% | |
NR7 | Range Contraction | 5.59% | |
Wide Bands | Range Expansion | 5.59% | |
Fell Below 20 DMA | Bearish | 6.53% | |
Wide Bands | Range Expansion | 6.53% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Possible Pocket Pivot | 1 day ago |
60 Minute Opening Range Breakout | 2 days ago |
Rose Above Upper Bollinger Band | 2 days ago |
Up 3% | 2 days ago |
Up 2% | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2023
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 21.98 |
52 Week Low | 5.86 |
Average Volume | 166,556 |
200-Day Moving Average | 12.79 |
50-Day Moving Average | 7.86 |
20-Day Moving Average | 6.64 |
10-Day Moving Average | 6.79 |
Average True Range | 0.57 |
RSI (14) | 50.50 |
ADX | 13.82 |
+DI | 23.90 |
-DI | 20.06 |
Chandelier Exit (Long, 3 ATRs) | 7.13 |
Chandelier Exit (Short, 3 ATRs) | 7.57 |
Upper Bollinger Bands | 7.31 |
Lower Bollinger Band | 5.97 |
Percent B (%b) | 0.9 |
BandWidth | 20.14 |
MACD Line | -0.29 |
MACD Signal Line | -0.45 |
MACD Histogram | 0.1529 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.05 | ||||
Resistance 3 (R3) | 7.97 | 7.60 | 7.91 | ||
Resistance 2 (R2) | 7.60 | 7.38 | 7.64 | 7.86 | |
Resistance 1 (R1) | 7.39 | 7.24 | 7.50 | 7.47 | 7.81 |
Pivot Point | 7.02 | 7.02 | 7.07 | 7.06 | 7.02 |
Support 1 (S1) | 6.81 | 6.80 | 6.92 | 6.89 | 6.55 |
Support 2 (S2) | 6.44 | 6.66 | 6.48 | 6.50 | |
Support 3 (S3) | 6.23 | 6.44 | 6.46 | ||
Support 4 (S4) | 6.31 |